OUR IMPACT
PHASE ONE has provided 48 grants for research in 24 different types of cancer.
Our investment of $23 million has resulted in over $90 million in additional major funding, including the National Institutes of Health (NIH), for our grant recipients.
PHASE ONE has assisted with bringing 2 live-saving drugs to market and more approved treatments on the horizon.